On July 31, 2024, Ami Vaccine Co., Ltd. submitted the latest monthly securities report. The report shows that the company's registered capital and issued shares remained unchanged in that month. The registered capital and issued shares of H shares remained at 492,173,711 shares, with a face value of 1 yuan per share; the registered capital and issued shares of domestic shares remained at 718,888,888 shares, also with a face value of 1 yuan per share. In addition, the number of share options under the company's first employee share incentive plan has decreased from 3,201,000 to 3,141,000. The report was submitted to the Hong Kong Stock Exchange and Clearing Limited by joint company secretary Liu Ling on August 2, 2024.

On July 31, 2024, Ami Vaccine Co., Ltd. submitted the latest monthly securities report. The report shows that the company's registered capital and issued shares remained unchanged in that month. The registered capital and issued shares of H shares remained at 492,173,711 shares, with a face value of 1 yuan per share; the registered capital and issued shares of domestic shares remained at 718,888,888 shares, also with a face value of 1 yuan per share. In addition, the number of share options under the company's first employee share incentive plan has decreased from 3,201,000 to 3,141,000. The report was submitted to the Hong Kong Stock Exchange and Clearing Limited by joint company secretary Liu Ling on August 2, 2024.